Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.

Mas S, Llerena A, Saíz J, Bernardo M, Lafuente A.

Pharmacogenomics. 2012 Nov;13(15):1773-82. doi: 10.2217/pgs.12.159. Review.

PMID:
23171340
2.
3.

Pharmacogenetics of psychotropic drug response.

Malhotra AK, Murphy GM Jr, Kennedy JL.

Am J Psychiatry. 2004 May;161(5):780-96. Review.

PMID:
15121641
4.

Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs).

Bernardo M, Bioque M, Parellada M, Saiz Ruiz J, Cuesta MJ, Llerena A, Sanjuán J, Castro-Fornieles J, Arango C, Cabrera B; PEPs Group.

Rev Psiquiatr Salud Ment. 2013 Jan-Mar;6(1):4-16. doi: 10.1016/j.rpsm.2012.11.001. Epub 2012 Dec 1. English, Spanish.

5.

Advances in the pharmacogenetic prediction of antipsychotic response.

Arranz MJ, Kerwin RW.

Toxicology. 2003 Oct 1;192(1):33-5.

PMID:
14511901
6.

Pharmacogenetics and outcome with antipsychotic drugs.

Pouget JG, Shams TA, Tiwari AK, Müller DJ.

Dialogues Clin Neurosci. 2014 Dec;16(4):555-66. Review.

7.

The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.

Zivković M, Mihaljević-Peles A, Sagud M, Silić A, Mihanović M.

Psychiatr Danub. 2010 Mar;22(1):112-6.

8.

[Pharmacogenetics in psychiatry: how far are we from clinical application?].

Daray FM, Maffia PC, Rothlin RP, Errasti AE.

Vertex. 2012 Jul-Aug;23(104):299-309. Review. Spanish.

PMID:
23170302
9.

Pharmacogenetic testing in psychiatry: a review of features and clinical realities.

de Leon J, Arranz MJ, Ruaño G.

Clin Lab Med. 2008 Dec;28(4):599-617. doi: 10.1016/j.cll.2008.05.003. Review.

PMID:
19059065
10.

Pharmacogenetics of antipsychotics: recent progress and methodological issues.

Zhang JP, Malhotra AK.

Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):183-91. doi: 10.1517/17425255.2013.736964. Epub 2012 Dec 1. Review.

11.

CYP 2D6 polymorphism and antipsychotic therapy.

Plesnicar BK, Dolzan V, Zalar B.

Psychiatr Danub. 2008 Sep;20(3):369-71.

PMID:
18827765
12.

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.

Reynolds GP, Templeman LA, Zhang ZJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1021-8. Review.

PMID:
15953671
13.

Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies.

Rietschel M, Kennedy JL, Macciardi F, Meltzer HY.

Schizophr Res. 1999 May 25;37(2):191-6. Review. No abstract available.

PMID:
10374654
14.

Pharmacogenetics and psychoactive drug therapy: ready for the patient?

Steimer W.

Ther Drug Monit. 2010 Aug;32(4):381-6. doi: 10.1097/FTD.0b013e3181e1a78d. Review.

PMID:
20526233
15.

Clinical applications of pharmacogenetics in psychiatry.

Staddon S, Arranz MJ, Mancama D, Mata I, Kerwin RW.

Psychopharmacology (Berl). 2002 Jun;162(1):18-23. Epub 2002 Apr 25. Review.

PMID:
12107612
16.

Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics.

Abdolmaleky HM, Zhou JR, Thiagalingam S, Smith CL.

Pharmacogenomics. 2008 Dec;9(12):1809-23. doi: 10.2217/14622416.9.12.1809. Review.

PMID:
19072640
17.

Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.

Vandel P, Talon JM, Haffen E, Sechter D.

Curr Pharm Des. 2007;13(2):241-50. Review.

PMID:
17269931
18.

Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes.

Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh BZ, Snieder H; GROUP investigators.

Eur Neuropsychopharmacol. 2012 Sep;22(9):625-31. doi: 10.1016/j.euroneuro.2012.01.006. Epub 2012 Mar 3.

19.

Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.

Risselada AJ, Mulder H, Heerdink ER, Egberts TC.

Pharmacogenomics. 2011 Aug;12(8):1213-27. doi: 10.2217/pgs.11.67. Review.

PMID:
21843067
20.

Genomics and the future of pharmacotherapy in psychiatry.

Malhotra AK, Lencz T, Correll CU, Kane JM.

Int Rev Psychiatry. 2007 Oct;19(5):523-30. Review.

PMID:
17896232

Supplemental Content

Support Center